epirubicin , a stereoisomer of doxorubicin with suggested lower potential for cardiotoxicity in animal tumor systems , was evaluated in a disease-oriented phase ii trial in non-small cell lung cancer .
C0014582
epirubicin
C0013089
doxorubicin